Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Hainan Poly Pharm’s Generic Ganciclovir Approved in Denmark

January 25, 2025
CompanyDrug

Jacobio Pharma Doses First Patient in US Phase I/IIa Study for JAB-2485

January 25, 2025
CompanyDeals

VACSERA in Talks with Sinovac to Establish Integrated Vaccine Plant

January 25, 2025
CompanyDrug

Eisai CEO Outlines Ambitions for Alzheimer’s Drug Leqembi After FDA Approval

January 25, 2025
CompanyDrug

Dizal’s Sunvozertinib and Golidocitinib Combo Gets NMPA Approval for Phase II Study

January 26, 2025
CompanyDrug

Luye Pharma’s BA1301 Receives CDE Approval for Clinical Trials

January 26, 2025
Policy / Regulatory

China’s National Health Commission Releases Updated COVID-19 Treatment Plan

January 26, 2025
CompanyDrug

HutchMed’s Sovleplenib Administered to First Patient in Phase II COVID-19 Study

January 26, 2025
CompanyMedical Device

Zai Lab and Novocure’s TTFields Device Shows Survival Benefit in Lung Cancer Study

January 26, 2025
CompanyDrug

Salubris Pharmaceuticals Gains NMPA Approval for Phase I Study of SAL0133

January 26, 2025
CompanyDeals

Kactus Biosystems Partners with Bioheng for Cell Therapy Raw Materials

September 1, 2025
CompanyDeals

Immune-Onc Therapeutics Completes $131 Million Series B Financing

January 26, 2025
1 2 … 13 14 15 16 17 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up